- Home
- BKE vs BHC Comparison
BKE vs BHC Comparison
Compare BKE & BHC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BKE
- BHC
- Stock Information
- Founded
- BKE 1948
- BHC N/A
- Country
- BKE United States
- BHC Canada
- Employees
- BKE N/A
- BHC N/A
- Industry
- BKE Clothing/Shoe/Accessory Stores
- BHC Biotechnology: Pharmaceutical Preparations
- Sector
- BKE Consumer Discretionary
- BHC Health Care
- Exchange
- BKE Nasdaq
- BHC Nasdaq
- Market Cap
- BKE 2.9B
- BHC 2.4B
- IPO Year
- BKE 1992
- BHC N/A
- Fundamental
- Price
- BKE $56.93
- BHC $6.38
- Analyst Decision
- BKE Hold
- BHC Hold
- Analyst Count
- BKE 1
- BHC 2
- Target Price
- BKE $54.00
- BHC $9.00
- AVG Volume (30 Days)
- BKE 526.3K
- BHC 1.7M
- Earning Date
- BKE 11-21-2025
- BHC 10-29-2025
- Dividend Yield
- BKE 6.66%
- BHC N/A
- EPS Growth
- BKE N/A
- BHC N/A
- EPS
- BKE 4.00
- BHC 0.27
- Revenue
- BKE $1,250,675,000.00
- BHC $9,858,000,000.00
- Revenue This Year
- BKE $4.30
- BHC $6.28
- Revenue Next Year
- BKE $5.67
- BHC $3.76
- P/E Ratio
- BKE $14.64
- BHC $24.09
- Revenue Growth
- BKE 1.62
- BHC 7.13
- 52 Week Low
- BKE $33.12
- BHC $4.25
- 52 Week High
- BKE $61.69
- BHC $9.85
- Technical
- Relative Strength Index (RSI)
- BKE 44.15
- BHC 38.57
- Support Level
- BKE $56.64
- BHC $6.40
- Resistance Level
- BKE $58.67
- BHC $6.81
- Average True Range (ATR)
- BKE 1.19
- BHC 0.18
- MACD
- BKE -0.53
- BHC -0.02
- Stochastic Oscillator
- BKE 7.05
- BHC 5.00
About BKE Buckle Inc. (The)
Buckle Inc is a retailer of casual apparel, footwear, and accessories. The company retails medium to affordable priced casual apparel, footwear, and accessories for fashion-conscious young men and women. It retails under the brand names 'Buckle' and 'The Buckle'. Buckle markets a wide selection of mostly brand-name casual apparel including denim, other casual bottoms, tops, sportswear, outerwear, accessories, and footwear.
About BHC Bausch Health Companies Inc.
Bausch Health Companies Inc is a world-wide specialty pharmaceutical, consumer health, and medical device company with a focus on branded products for the gastroenterology, hepatology, neurology and dermatology markets. The company reports revenue in five segments: Salix; International; Solta Medical; Diversified Products and Bausch + Lomb. It generates maximum revenue from the Bausch + Lomb segment.